Atria Wealth Solutions’s Transmedics TMDX Stock Holding History

Atria Wealth Solutions’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$316K	Buy	+2,442	New	+$268K	0.01%	1132
2025 Q1	–	Sell	-6,769	Closed	-$422K	–	2075
2024 Q4	$422K	Sell	6,769 -1,900	-22%	-$177K	﹤0.01%	1359
2024 Q3	$1.36M	Buy	8,669 +1,701	+24%	+$262K	0.01%	799
2024 Q2	$1.05M	Sell	6,968 -1,088	-14%	-$131K	0.01%	874
2024 Q1	$596K	Buy	8,056 +2,796	+53%	+$230K	0.01%	1181
2023 Q4	$415K	Buy	+5,260	New	+$317K	0.01%	1309

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atria Wealth Solutions's TMDX Position: Q2 2025 in Review

Atria Wealth Solutions opened a new position in Transmedics (TMDX) in Q2 2025: 2,442 shares worth $316K. The stake represents 0.01% of the portfolio and ranks #1132 among its holdings. This is a return to the name: Atria Wealth Solutions previously reported a position in TMDX as recently as Q4 2024.

Atria Wealth Solutions first reported a position in TMDX in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.36M in Q3 2024. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

Atria Wealth Solutions held 2,442 shares of Transmedics worth $316K as of Q2 2025.
Transmedics was a new Atria Wealth Solutions position in Q2 2025.
Transmedics made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1132 holding.
Atria Wealth Solutions first reported a position in Transmedics in Q4 2023 and has held it in 6 quarters since.
Atria Wealth Solutions's Transmedics position peaked at $1.36M in Q3 2024.
368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.